Post-earnings recap
Reported
Wed, Nov 8, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported a better-than-expected EPS for the third quarter, exceeding estimates by 15.55%. However, the stock reacted negatively, dropping 3.74%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.72 | N/A | +15.55% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.